CCL19 and COVID-19: In conclusion, our work supports further clinical investigation correlating prognosis by stratifying patients based on the circulating molecules involved in complement activation shown recently (Ma et al., 2021), or characteristic cytokines such as CCL19, implicated in COVID-19 mortality (Balnis et al., 2021).